Ten63 Therapeutics Closes Strategic Financing for AI Drug Discovery
SOSV portfolio company and graduate of the IndieBio progrmam, Ten63 Therapeutics recently announced that it added strategic investment from new investors Chugai Venture Fund and...
Tag : Closes
Cayuga Closes $8M Seed Funding & Doses First Patient in Phase 1 Clinical Trial
We’re excited to share two major milestones from our SOSV portfolio company Cayuga, which is developing a novel therapeutic approach to address life-threatening hemorrhage. Hemorrhage...